{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:28:16Z","timestamp":1777724896690,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.parkreldis.2026.108205","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:37:38Z","timestamp":1769560658000},"page":"108205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Neuromelanin-sensitive MRI as a biomarker for individualized deep brain stimulation in Parkinson's disease: Associations between substantia nigra imaging and therapeutic outcomes"],"prefix":"10.1016","volume":"144","author":[{"given":"Yinling","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yindi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3138-2323","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2026.108205_bib1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J Neural Transm"},{"key":"10.1016\/j.parkreldis.2026.108205_bib2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2401857","article-title":"Parkinson's disease","volume":"391","author":"Tanner","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2026.108205_bib3","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2174\/1570159X15666170510143821","article-title":"Levodopa in parkinson's disease: current status and future developments","volume":"16","author":"Tambasco","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.parkreldis.2026.108205_bib4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jamaneurol.2025.3373","article-title":"Five-year outcomes from deep brain stimulation of the subthalamic nucleus for parkinson disease","volume":"82","author":"Starr","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.parkreldis.2026.108205_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2377-7-7","article-title":"Subthalamic nucleus deep brain stimulation in elderly patients--analysis of outcome and complications","volume":"7","author":"Vesper","year":"2007","journal-title":"BMC Neurol."},{"key":"10.1016\/j.parkreldis.2026.108205_bib6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/mds.29317","article-title":"Clinical diagnostic accuracy of parkinson's disease: where do we stand?","volume":"38","author":"Virameteekul","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108205_bib7","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/01.wnr.0000227984.84927.a7","article-title":"Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in parkinson's disease","volume":"17","author":"Sasaki","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.parkreldis.2026.108205_bib8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00234-013-1171-8","article-title":"3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of parkinson's disease","volume":"55","author":"Ogisu","year":"2013","journal-title":"Neuroradiology"},{"key":"10.1016\/j.parkreldis.2026.108205_bib9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fnagi.2016.00196","article-title":"Neuromelanin imaging and dopaminergic loss in parkinson's disease","volume":"8","author":"Isaias","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.parkreldis.2026.108205_bib10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/ene.13628","article-title":"Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo parkinson's disease and its phenotypes","volume":"25","author":"Wang","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2026.108205_bib11","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1093\/brain\/awab191","article-title":"The spatiotemporal changes in dopamine, neuromelanin and iron characterizing parkinson's disease","volume":"144","author":"Biondetti","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2026.108205_bib12","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.4103\/0366-6999.164925","article-title":"Long-term efficacy of subthalamic nucleus deep brain stimulation in parkinson's disease: a 5-year follow-up study in China","volume":"128","author":"Jiang","year":"2015","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.parkreldis.2026.108205_bib13","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mds.29410","article-title":"Levodopa dose equivalency in parkinson's disease: updated systematic review and proposals","volume":"38","author":"Jost","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108205_bib14","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.neurol.2020.02.009","article-title":"Deep brain stimulation programming in parkinson's disease: introduction of current issues and perspectives","volume":"176","author":"Aubignat","year":"2020","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.parkreldis.2026.108205_bib15","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.mri.2014.07.003","article-title":"Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach","volume":"32","author":"Chen","year":"2014","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.parkreldis.2026.108205_bib16","article-title":"Nigral volume loss in prodromal, early, and moderate parkinson's disease","volume":"11","author":"Langley","year":"2025","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.parkreldis.2026.108205_bib17","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/j.crad.2023.09.019","article-title":"Improved diagnostic performance of susceptibility-weighted imaging with compressed sensing-sensitivity encoding and neuromelanin-sensitive MRI for parkinson's disease and atypical parkinsonism","volume":"79","author":"Lee","year":"2024","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.parkreldis.2026.108205_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00471","article-title":"Application of multimodal deep learning and multi-instance learning fusion techniques in predicting STN-DBS outcomes for parkinson's disease patients","volume":"21","author":"Chang","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.parkreldis.2026.108205_bib19","doi-asserted-by":"crossref","first-page":"fcad171","DOI":"10.1093\/braincomms\/fcad171","article-title":"A structural magnetic resonance imaging review of clinical motor outcomes from deep brain stimulation in movement disorders","volume":"5","author":"Andrews","year":"2023","journal-title":"Brain Commun."},{"key":"10.1016\/j.parkreldis.2026.108205_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-023-03350-z","article-title":"An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with parkinson's disease using neuromelanin-sensitive MRI","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Neurol."},{"key":"10.1016\/j.parkreldis.2026.108205_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nicl.2017.07.011","article-title":"Diffusion tensor imaging in parkinson's disease: review and meta-analysis","volume":"16","author":"Atkinson-Clement","year":"2017","journal-title":"Neuroimage, Clin."},{"key":"10.1016\/j.parkreldis.2026.108205_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/WCO.0000000000000226","article-title":"Deep brain stimulation for movement disorders: 2015 and beyond","volume":"28","author":"Fasano","year":"2015","journal-title":"Curr. Opin. Neurol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:52:50Z","timestamp":1772520770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802026000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":22,"alternative-id":["S1353802026000313"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108205","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuromelanin-sensitive MRI as a biomarker for individualized deep brain stimulation in Parkinson's disease: Associations between substantia nigra imaging and therapeutic outcomes","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108205"}}